The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Rompe Tos X Children
Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl · ACETAMINOPHEN 250 mg/10mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 13.33 mg/10mL; GUAIFENESIN 200 mg/10mL · Syrup · Oral · Opmx Llc
NDC 69729-0784-06 · 1 BOTTLE, PLASTIC in 1 CARTON / 177 mL in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl (Syrup)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Opmx Llc | ACETAMINOPHEN 250 mg/10mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 13.33 mg/10mL; GUAIFENESIN 200 mg/10mL | Aug 26, 2026 | Sep 3, 2026 |
| Opmx Llc | ACETAMINOPHEN 500 mg/20mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/20mL; DEXTROMETHORPHAN HYDROBROMIDE 26.66 mg/20mL; GUAIFENESIN 400 mg/20mL | Aug 26, 2026 | Sep 3, 2026 |
| Haleon US Holdings LLC | ACETAMINOPHEN 650 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Opmx Llc | ACETAMINOPHEN 500 mg/20mL; PHENYLEPHRINE HYDROCHLORIDE 26.66 mg/20mL; DEXTROMETHORPHAN HYDROBROMIDE 400 mg/20mL; GUAIFENESIN 10 mg/20mL | Jul 22, 2026 | Aug 21, 2026 |
| Opmx Llc | ACETAMINOPHEN 250 mg/10mL; PHENYLEPHRINE HYDROCHLORIDE 13.33 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 200 mg/10mL; GUAIFENESIN 5 mg/10mL | Jul 22, 2026 | Aug 20, 2026 |
| Opmx Llc | ACETAMINOPHEN 500 mg/20mL; DEXTROMETHORPHAN HYDROBROMIDE 26.66 mg/20mL; GUAIFENESIN 400 mg/20mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/20mL | Jul 15, 2026 | Jul 19, 2026 |
| Opmx Llc | ACETAMINOPHEN 250 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 13.33 mg/10mL; GUAIFENESIN 200 mg/10mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/10mL | Jul 15, 2026 | Jul 16, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Rompe Tos X Children — NDC 69729-0784-06," retrieved September 3, 2026, https://drugdashboards.com/drug/69729078406.
Free to cite with attribution — see how the data is put together.